UBS Group’s Immunomedics Inc IMMU Stock Holding History

UBS Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,200	Closed	-$20K	–	9633
2014 Q4	$20K	Buy	+4,200	New	+$16.6K	﹤0.01%	7698

UBS Group's IMMU Position: Q4 2020 in Review

UBS Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 291,642 shares — an estimated $24.8M sold.

UBS Group first reported a position in IMMU in Q4 2014 and held it in 24 quarters. The position peaked at $24.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

UBS Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
UBS Group sold 291,642 Immunomedics Inc shares in Q4 2020, an estimated $24.8M.
UBS Group first reported a position in Immunomedics Inc in Q4 2014 and held it in 24 quarters.
UBS Group's Immunomedics Inc position peaked at $24.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.